#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Herpes simplex Glomerulonephritis rapidly progressive Marfan's syndrome Non-small cell lung cancer metastatic Vascular malformation Biliary neoplasm Fungal infection Hepatocellular carcinoma Glomerulonephritis chronic Renal transplant Neurodevelopmental disorder Immune-mediated myasthenia gravis Acute hepatic failure White matter lesion Arteriosclerosis More trials…

    Learn about Rare Diseases

    Proteus syndrome – Diagnostics Hereditary angioedema with C1 esterase inhibitor deficiency – Basic Information Primary biliary cholangitis – Basic Information Uterine leiomyosarcoma Haemophagocytic lymphohistiocytosis – Basic Information Focal segmental glomerulosclerosis – Diagnostics Testicular leiomyosarcoma Prolymphocytic leukaemia – Diagnostics Synovial sarcoma Mucopolysaccharidosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vesleteplirsen REGN7999 Somatostatin Tofacitinib BENZYDAMINE HYDROCHLORIDE Secale Cereale Isis 678354 Sodium Salt Eprosartan Mesilate Ima402 Ly3298176 Abrocitinib Glucagon Human Serum Albumin 5% Specific Nucleic Acid Sna-Xfsc Vericiguat Dexamfetamine Sulfate Omp64 Rezafungin Acetate Ecoo6A Barium Sulfate More therapies…

    Learn about Your Condition

    Endometrial cancer stage IV Neuralgia Hepatitis D Gender dysphoria Hidradenitis Coronary artery occlusion Factor VIII deficiency Precocious puberty Trigeminal neuralgia Dizziness Macular oedema Psychogenic seizure Mucopolysaccharidosis II Pleural mesothelioma Breast neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Fondation A De Rothschild

Fondation A De Rothschild

29 Rue Manin, Paris, 75019, France

Want to learn more about this study or check if you can participate? Contact us.

  • A Phase 3 Randomized Study of Rozanolixizumab for Safety and Efficacy in Adults with Ocular Myasthenia Gravis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Ocular myasthenia
    Investigated Drugs:
    • Rozanolixizumab
    France Germany Greece Hungary Italy Poland +1

  • Safety and Tolerability of PTI5803 in Patients Aged 14 Years and Older With Drug‑Resistant Seizures Due to Focal Cortical Dysplasia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Epilepsy
    France

  • Comparing tenecteplase and mechanical clot removal versus mechanical clot removal alone for adults with a large ischemic stroke

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Tenecteplase
    France

  • Treatment of Severe Eye Chemical Burns with Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells for Patients with Severe Ocular Chemical Burns

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Fluorescein Sodium
    • Human Serum Albumin
    • Ibuprofen
    France

  • Study on Rituximab, Tocilizumab, and Tofacitinib for Patients with Granulomatosis with Polyangiitis Not Responding to Standard Therapy

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Granulomatosis with polyangiitis
    Investigated Drugs:
    • Tofacitinib
    • Azathioprine
    • Methotrexate
    France

  • Study on Redasemtide for Adults with Acute Ischemic Stroke Not Eligible for Standard Treatments

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Redasemtide
    Belgium Czechia Denmark Finland France Germany +3

  • Faricimab for Choroidal Neovascularization Secondary to Pathologic Myopia in Patients with Pathologic Myopia

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Choroidal neovascularisation
    Investigated Drugs:
    • Faricimab
    • Ranibizumab
    France Germany Italy Poland Spain

  • Study on the Effectiveness and Safety of EYE103 Compared to Ranibizumab for Patients with Diabetic Macular Edema

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Diabetic retinal oedema
    Investigated Drugs:
    • Eye103
    • Fluorescein Sodium
    • Ranibizumab
    Austria Croatia Czechia France Germany Hungary +6

  • Study on the Effects of Remibrutinib for Patients with Generalized Myasthenia Gravis

    Not recruiting

    3 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Remibrutinib
    Belgium France Germany Italy The Netherlands Poland +2

  • Study on the Safety and Effects of NVG-2089 for Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    Not recruiting

    2 1 1
    Investigated Drugs:
    • NVG-2089
    Belgium Bulgaria France Italy Poland Spain
Previous Page
1 … 3 4 5 6 7 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!